181 – 190 of 324
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Use and limitations of APTT as a screening test for mild bleeding disorders
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in parents of children with haemophilia - results of the ESCHQoL study
- Contribution to journal › Published meeting abstract
-
Mark
Network activities were initiated in December, 2009, and will extend over the next five years. von Willebrand disease prophylaxis network
(2010) 3rd Annual Congress of the European Association for Haemophilia and Allied Disorders In Haemophilia 16(2). p.403-403
- Contribution to journal › Published meeting abstract
-
Mark
F8 haplotype and recombinant product use in the Hemophilia Inhibitor Genetics Study (HIGS)
- Contribution to journal › Published meeting abstract
-
Mark
European initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
- Contribution to journal › Published meeting abstract
-
Mark
Influence of the pre-analytical specimen storage conditions on thrombin generation assay
(2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.45-45
- Contribution to journal › Published meeting abstract
-
Mark
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
- Contribution to journal › Article
-
Mark
Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10).
- Contribution to journal › Article
-
Mark
Thrombin generation in vitro in the presence of by-passing agents in siblings with severe haemophilia A.
- Contribution to journal › Article
-
Mark
Inhibitor development: patient-determined risk factors.
- Contribution to journal › Article
